Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Peripheral Vascular Diseases

• A Study of Loco-Regional Liposomal Bupivacaine Injection
• A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.
• Selective Spinal Anaesthesia With Hyperbaric Prilocain With 2%Provides Better Perioperative Hemodynamic Stability for Patients With Peripheral Vascular Disease and Cardiac Dysfunction in Lower Limb Surgery
• The Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography
• VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
• The Effects of Allicor on Patients After Revascularization Treatment During a Year
• Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?
• Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
• A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease
• The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy
• Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization
• The Effects of Oral Inorganic Nitrate Supplementation on Lower Limb Perfusion During Exercise in Patients With PAD
• The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
• Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease
• Liraglutide and Peripheral Artery Disease
• Carnosine for Peripheral Arterial Disease
• The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
• Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
• Pulsed Electromagnetic Field Versus Treadmill Walking in Peripheral Arterial Disease
• Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease.
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
• Creatine Use and Muscle Stretching in Peripheral Artery Disease
• Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease
• Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
• Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients
• Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis
• Effects of Esmolol Infusion on Hemodynamic Responses to Isometric Handgrip
• Ultrasound Evaluation of Lower Extremity Arteries After Topical Nitroglycerin Administration
• Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
• The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
• Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
• "Unifuzol®" in Patients With Peripheral Arterial Disease
• Carnosine for Peripheral Vascular Disease
• Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies
• VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.
• Pilot Study of Vitamin D Screening Use in Peripheral Arterial Disease Patient Over Maximum Distance Walking
• Arterial Imaging of Inflammation and Resolution After Endovascular Surgery
• Effect of Topical Anesthesia on Patient's Pain Discomfort and Radial Artery Spasm in Transradial Catheterization
• Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery Disease
• Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB
• Chelation Therapy in Diabetic Patients With Critical Limb Ischemia
• Peripheral Nerve Blocks for Above-the-knee Amputations
• Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
• Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication
• Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease
• Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
• N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes
• Angiotensin-(1-7) in Peripheral Arterial Disease
• Influence of Vorapaxar on Thrombin Generation and Coagulability
• The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
• The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
• Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs
• Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction
• Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers
• Angiosome Perfusion After Tibial Bypass
• SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study
• A Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease
• Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
• Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.
• Ramipril Treatment of Claudication
• Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
• A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese
• PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses
• Cilostazol Following Peripheral Endovascular Procedures
• Post-operative Treatment of Diabetic Peripheral Arterial Disease Guided by Platelet Reactivity Unit
• Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
• Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease
• Influence of Vorapaxar on Thrombin Generation and Coagulability
• Ultrasound to Enhance Paclitaxel Uptake in Critical Limb Ischemia: the PACUS Trial
• Effect of Beetroot Juice on Coronary Blood Flow and Walking Performance in PAD
• Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus
• Delivery of Yamani-15/5 Chemical Solution for PAD
• Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
• Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease
• Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization
• Ticagrelor and Peripheral Arterial Disease
• Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease
• Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication
• Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
• Cilostazol After Lower Extremity Arterial Revascularization Trial
• Exparel as a Nerve Block for Severe Hand Pain
• Randomized Phase IIb Trial of DVC1-0101
• RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
• Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia
• Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
• Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia
• DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease
• 3 Month PHI PAD PoM Study
• Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
• Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)
• Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication
• Edoxaban in Peripheral Arterial Disease
• The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication
• Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD
• Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease
• Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
• Nitrites, Exercise, and Peripheral Arterial Disease
• Residual Platelet Activity In Advanced Peripheral Artery Disease
• Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention
• Vitamin D and Walking Ability in Patients With Peripheral Artery Occlusive Disease
• Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose
• A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
• The Evening Versus Morning Polypill Utilization Study
• Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure
• Iloprost Therapy in Patients With Critical Limb Ischemia
• Effects of Paclitaxel on Intimal Hyperplasia
• Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)
• Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium
• Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC
• Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease
• OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease
• The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)
• Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty
• Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease
• PF-00489791 For The Treatment Of Raynaud's
• Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease
• Granulocyte-Macrophage Stimulating Factor in the Treatment of Peripheral Arterial Disease
• Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
• Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities
• The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)
• Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease
• Intermittent Mechanical Compression For Peripheral Arterial Disease
• Evaluation of Cilostazol in Combination With L-Carnitine
• Local Paclitaxel Delivery for SFA Disease
• A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial Diseases
• Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease
• A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).
• Endothelial Function in Lower Extremity Bypass Grafts
• Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.
• Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)
• Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
• Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease
• A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)
• Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)
• Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)
• Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
• Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
• Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function
• Comprehensive Magnetic Resonance of Peripheral Arterial Disease
• Lovaza Therapy of Peripheral Arterial Disease
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)
• Prevention of Restenosis Following Revascularization
• Testosterone for Peripheral Vascular Disease
• Clinical Utility of Endothelial Dysfunction in PAD
• Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
• Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease
• Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
• Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
• Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease
• FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
• Crossover Study With MultiHance vs a Comparator for Peripheral MRA
• A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease
• Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)
• Penetration of Ertapenem Into Bone
• RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
• Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease
• Testosterone Replacement in Diabetes With Vascular Disease (Version 2)
• Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease
• Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery
• Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia
• Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease
• L-Arginine in the Treatment of Peripheral Arterial Disease
• PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients
• The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)
• Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries
• CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease
• The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease
• Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel
• Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease
• Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures
• ARREST PAD (Peripheral Arterial Disease)
• Platelets Induced Vasodilation, in Vitro and in Vivo Study
• Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease
• Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)
• Warfarin and Antiplatelet Vascular Evaluation
• Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
• Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
• Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication
• Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
• The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC
• Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft
• Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication
• Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
• Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
• Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
• Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease
• Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
• Extract of Ginkgo Biloba (EGB 761) and Vascular Function
• Prevention of Recurrent Venous Thromboembolism (PREVENT)